The genomic amplification-driven and multi-targeted transcriptional regulation pattern of ZKSCAN3 revealed in cervical cancer provides new perspectives to explore its cross-organ oncogenic mechanism in prostate cancer. This evidence concerns the gene ZKSCAN3 and prostate carcinoma.